Sara Gagno

725 total citations
42 papers, 548 citations indexed

About

Sara Gagno is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Sara Gagno has authored 42 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Genetics. Recurrent topics in Sara Gagno's work include Chronic Lymphocytic Leukemia Research (11 papers), Advanced Breast Cancer Therapies (10 papers) and Gastrointestinal Tumor Research and Treatment (7 papers). Sara Gagno is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Advanced Breast Cancer Therapies (10 papers) and Gastrointestinal Tumor Research and Treatment (7 papers). Sara Gagno collaborates with scholars based in Italy, Ukraine and Spain. Sara Gagno's co-authors include Giuseppe Toffoli, Bianca Posocco, Erika Cecchin, Rossana Roncato, Michela Guardascione, Marcella Montico, Elena De Mattia, Angela Buonadonna, Fabio Puglisi and Simona Scalone and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

Sara Gagno

42 papers receiving 542 citations

Peers

Countries citing papers authored by Sara Gagno

Since Specialization

Citations

This map shows the geographic impact of Sara Gagno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Gagno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Gagno more than expected).

Fields of papers citing papers by Sara Gagno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Gagno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Gagno. The network helps show where Sara Gagno may publish in the future.

Co-authorship network of co-authors of Sara Gagno

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Gagno. A scholar is included among the top collaborators of Sara Gagno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Gagno. Sara Gagno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Imatinib and norimatinib therapeutic monitoring using dried blood spots: Analytical and clinical validation, and performance comparison of volumetric collection devices 2025 ·Journal of Chromatography B ·(unknown), Sara Gagno, (unknown), Marcella Montico, Angela Buonadonna, (unknown), Michela Guardascione, Fabio Puglisi, Giuseppe Toffoli, Bianca Posocco, Erika Cecchin	2
2	Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series 2024 ·Frontiers in Immunology ·Sara Gagno, Bianca Posocco, (unknown), (unknown), (unknown), Michela Guardascione, Angela Buonadonna, Jerry Polesel, Fabio Puglisi, Giuseppe Toffoli, Erika Cecchin	2
3	Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method 2024 ·Therapeutic Drug Monitoring ·Bianca Posocco, (unknown), (unknown), Sara Gagno, Marcella Montico, (unknown), Rossana Roncato, Lorenzo Gerratana, Serena Corsetti, Fabio Puglisi, Giuseppe Toffoli	3
4	Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug–gene interactions 2024 ·Frontiers in Pharmacology ·(unknown), Bianca Posocco, Lorenzo Gerratana, (unknown), (unknown), Sara Gagno, Elena De Mattia, Fabio Puglisi, Erika Cecchin, Giuseppe Toffoli, Rossana Roncato	2
5	LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 2023 ·Pharmaceutics ·(unknown), (unknown), Bianca Posocco, Sara Gagno, Alessia Bignucolo, Marcella Montico, Rossana Roncato, Serena Corsetti, Michele Bartoletti, Giuseppe Toffoli	12
6	Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas 2023 ·Cancers ·Angela Buonadonna, Simona Scalone, Davide Lombardi, (unknown), (unknown), Chiara Lestuzzi, Jerry Polesel, Vincenzo Canzonieri, Stefano Lamon, Petros Giovanis, Sara Gagno, Giuseppe Corona, Maurizio Mascarin, Claudio Belluco, Antonino De Paoli, Gianpiero Fasola, Fabio Puglisi, Gianmaria Miolo	1
7	Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis 2023 ·International Journal of Molecular Sciences ·(unknown), Jerry Polesel, Sara Gagno, Bianca Posocco, Elena De Mattia, Rossana Roncato, (unknown), Fabio Puglisi, Michela Guardascione, Angela Buonadonna, Giuseppe Toffoli, Erika Cecchin	10
8	The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure 2023 ·DARU Journal of Pharmaceutical Sciences ·Sara Gagno, Angela Buonadonna, (unknown), Michela Guardascione, (unknown), Bianca Posocco, (unknown), (unknown), Rossana Roncato, Erika Cecchin, Giuseppe Toffoli	2
9	Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg 2022 ·Cancer Chemotherapy and Pharmacology ·(unknown), Gudrun Würthwein, Pablo Zubiaur, Bianca Posocco, Maria Pena, Alberto M. Borobia, Sara Gagno, Francisco Abad‐Santos, Georg Hempel	4
10	“A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring” 2022 ·Journal of Chromatography B ·(unknown), Bianca Posocco, (unknown), Sara Gagno, (unknown), (unknown), (unknown), Fabio Puglisi, Giuseppe Toffoli	7
11	IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm 2021 ·Cancers ·Elena De Mattia, Jerry Polesel, Rossana Roncato, (unknown), Alessia Bignucolo, Sara Gagno, Angela Buonadonna, Mario D’Andrea, Éric Lévesque, Derek J. Jonker, Félix Couture, Chantal Guillemette, Erika Cecchin, Giuseppe Toffoli	8
12	A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring 2021 ·PLoS ONE ·(unknown), (unknown), Bianca Posocco, (unknown), (unknown), (unknown), (unknown), Michela Guardascione, Luisa Foltran, V. Fanotto, Fabio Puglisi, Sara Gagno, Giuseppe Toffoli	10
13	Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 2020 ·PLoS ONE ·Bianca Posocco, (unknown), (unknown), (unknown), Sara Gagno, (unknown), (unknown), Michela Guardascione, Fabio Puglisi, Debora Basile, Giacomo Pelizzari, Elena Marangon, Giuseppe Toffoli	34
14	New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach 2019 ·Cells ·Marica Garziera, Rossana Roncato, Marcella Montico, Elena De Mattia, Sara Gagno, Elena Poletto, Simona Scalone, Vincenzo Canzonieri, Giorgio Giorda, Roberto Sorio, Erika Cecchin, Giuseppe Toffoli	27
15	Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC) 2019 ·Cells ·Marica Garziera, Erika Cecchin, Giorgio Giorda, Roberto Sorio, Simona Scalone, Elena De Mattia, Rossana Roncato, Sara Gagno, Elena Poletto, (unknown), Fabrizio Ecca, Vincenzo Canzonieri, Giuseppe Toffoli	8
16	rs4143815-PDL1, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy 2019 ·International Journal of Molecular Sciences ·(unknown), Eva Dreussi, Roberto Bortolus, Chiara Romualdi, Sara Gagno, Elena De Mattia, (unknown), Franca Sartor, Luca Quartuccio, Erika Cecchin, Giuseppe Toffoli	5
17	Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients 2019 ·PLoS ONE ·(unknown), Bianca Posocco, (unknown), Marcella Montico, Elena Marangon, (unknown), (unknown), Sara Gagno, Angela Buonadonna, Michela Guardascione, Bruno Casetta, Giuseppe Toffoli	24
18	A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 2019 ·Gynecologic Oncology ·Sara Gagno, Elena Poletto, Michele Bartoletti, Luca Quartuccio, Chiara Romualdi, Marica Garziera, Simona Scalone, Roberto Sorio, Eva Dreussi, (unknown), Elena De Mattia, Rossana Roncato, Erika Cecchin, Giorgio Giorda, Salvatore De Vita, Michele Dal Bo, Fabio Puglisi, Giuseppe Toffoli	4
19	Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS) 2018 ·International Journal of Molecular Sciences ·Marica Garziera, Erika Cecchin, Vincenzo Canzonieri, Roberto Sorio, Giorgio Giorda, Simona Scalone, Elena De Mattia, Rossana Roncato, Sara Gagno, Elena Poletto, (unknown), Franca Sartor, Jerry Polesel, Giuseppe Toffoli	14
20	A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy 2018 ·Frontiers in Pharmacology ·Elena De Mattia, Eva Dreussi, Marcella Montico, Sara Gagno, (unknown), Luca Quartuccio, Salvatore De Vita, Michela Guardascione, Angela Buonadonna, Mario D’Andrea, Nicoletta Pella, Adolfo Favaretto, Enrico Mini, Stefania Nobili, (unknown), Erika Cecchin, Giuseppe Toffoli	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact